The impact of donor and recipient KIR genes and KIR ligands on the occurrence of acute graft-versus-host disease and graft survival after HLA-identical sibling hematopoietic stem cell transplantation

Background/aim: After allogeneic hematopoietic stem cell transplantation (allo-HSCT), donor natural killer (NK) cells trigger alloreactions against potential recipient cells by their killer immunoglobulin-like receptors (KIRs). This study investigated whether KIR/HLA genotypes and KIR haplotypes of donors and recipients exhibit a critical function in the prevalence of acute graft-versus-host disease (aGVHD) and persistence of the graft after HLA-identical sibling allo-HSCT for patients with hematological malignancies. Materials and methods: We studied KIR and HLA genotypes in 115 related donors and recipients (56 patients with AML and 59 patients with ALL) who had received allo-HSCT from HLA-matched sibling donors. We evaluated 17 KIR genes and some alleles, including their ligands, using the PCR-SSP assay. Results: KIR gene frequency results between donors and recipients showed that donors had more activating KIR than their recipients. Chi-square comparison of KIR genotype frequencies in donors versus recipients revealed a significant difference (P < 0.001). We found a survival association between the donor lacking and the recipient having group B KIR haplotypes, although this was not statistically significant. Conclusion: This study suggests that we could exploit NK cell alloreactivity as a part of the optimization of donor selection and potential immunotherapeutic regimens to help facilitate good engraftment and reduce the risk of aGVHD incidence after allo-HSCT.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Güler Ayşe BARUT, Mehtap TUNÇ, Şaziye ŞAHİN, Fatma ULUS, Hilal SAZAK

Jin LI, Hui LI, QI XIONG LI, Ying XUE

SİBEL OYUCU ORHAN, AHMET TEKTEMUR, NEVZAT GÖZEL, İBRAHİM HANİFİ ÖZERCAN, Servet YOLBAŞ, AHMET YILDIRIM, EBRU ÖNALAN, Süleyman Serdar KOCA

Özlem Güzel TUNÇCAN, AYŞE KALKANCI, Elif Ayça ÜNAL, Olkar ABDULMAJED, Merve ERDOĞAN, MURAT DİZBAY, Kayhan ÇAĞLAR

Leman Tekin ORGUN, Ebru ARHAN, Kürşad AYDIN, Tunzale RZAYEVA, Tuğba HIRFANOĞLU, AYŞE SERDAROĞLU

Betül Siyah BİLGİN, Özgün UYGUR, Demet TEREK, Özge Altun KÖROĞLU, Mehmet YALAZ, Mete AKISÜ, Muhsin Özgür ÇOĞULU, Nilgün KÜLTÜRSAY

ATİLLA ÇİFCİ, CÜNEYT TAYMAN, HALİL İBRAHİM YAKUT, Halit HALİL, ESRA ÇAKIR, Ufuk ÇAKIR, SALİH AYDEMİR

Umut KALYONCU, Etem Koray TAŞCILAR, Ali İhsan ERTENLİ, Hüseyin Ediz DALKILIÇ, Cemal BES, ORHAN KÜÇÜKŞAHİN, Timuçin KAŞİFOĞLU, Nilüfer Alpay KANITEZ, Hakan EMMUNGİL, GEZMİŞ KİMYON, Nazife Şule Yaşar BİLGE, Servet AKAR, Mehmet Pamir ATAGÜNDÜZ, SÜLEYMAN SERDAR KOCA, Aşkin ATEŞ, VELİ YAZISIZ, Mustafa Ender TERZİOĞLU, Em

Nur SOYER, Püsem PATIR, Ayşe UYSAL, Mustafa DURAN, Hatice Demet Kiper ÜNAL, İsabel Raika Durusoy ONMUŞ, Murat TOMBULOĞLU, Fahri ŞAHİN, Mahmut TÖBÜ, Filiz VURAL, Güray SAYDAM

Efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/ refractory multiple myeloma: a real-life experience

Mahmut TÖBÜ, Filiz VURAL, Murat TOMBULOĞLU, Ayşe UYSAL, Fahri ŞAHİN, Güray SAYDAM, Püsem PATIR, Hatice Demet ÜNAL, Nur SOYER, Mustafa DURAN, Raika DURUSOY